Jonathan McNeill - Jul 10, 2021 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Senior Vice President of Business Development
Signature
/s/ Richard Scalzo, Attorney-in-Fact
Stock symbol
DYN
Transactions as of
Jul 10, 2021
Transactions value $
$0
Form type
4
Date filed
7/13/2021, 04:22 PM
Next filing
Sep 22, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DYN Stock Option (right to buy) Award $0 +25K $0.00 25K Jul 10, 2021 Common Stock 25K $21.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on July 10, 2021. The shares underlying the option are scheduled to vest over four years in equal quarterly installments from July 1, 2021.

Remarks:

Senior Vice President of Business Development